Orlistat
Links shared publicly online about this topic
Liraglutide trumps orlistat in obesity trial
theheart.org — “A drug originally developed to treat diabetes may have promise as an obesity therapy, a new study shows. Those taking liraglutide, a GLP-1 analog, lost more weight than those on an established obesity medication, orlistat.” View full resource at theheart.org
Most Recently Shared on October 23, 2009 at 12:12 am By:
heartwire: GLP-1 analog liraglutide promising in obesity http://bit.ly/gK1Dv
Liraglutide trumps orlistat in obesity trial
m.theheart.org — “A drug originally developed to treat diabetes may have promise as an obesity therapy, a new study shows. Those taking liraglutide, a GLP-1 analog, lost more weight than those on an established obesity medication, orlistat.” View full resource at m.theheart.org
Most Recently Shared on October 23, 2009 at 1:26 am By:
heartwire: GLP-1 analog liraglutide promising in obesity http://bit.ly/2Wv2G4
Questions and Answers: Orlistat and Severe Liver Injury
fda.gov — “Questions and Answers: Orlistat and Severe Liver Injury” View full resource at fda.gov
Most Recently Shared on May 26, 2010 at 3:29 pm By:
eyeonfda Pharma and Health Lawyer
RT @FDAWomen: RT @FDA_Drug_Info: Questions and Answers: Orlistat and Severe Liver Injury. http://bit.ly/orlistat2
Orlistat (marketed as Alli and Xenical): Labeling Change
fda.gov — “Revised labeling to include cases of severe liver injury.” View full resource at fda.gov
Most Recently Shared on May 28, 2010 at 6:50 pm By:
madan kwatra Doctor and PhD
FDA News: liver injury and Orlistat. Orlistat (marketed as Alli and Xenical): Labeling Change: http://bit.ly/8ZrF4Y via @addthis
Concerns About Anti-Obesity Drug Orlistat
medicalnewstoday.com — “US authorities are investigating concerns that anti-obesity drug Orlistat may cause liver damage. Orlistat went on sale under the brand name Alli without the need for a prescription in t” View full resource at medicalnewstoday.com
Most Recently Shared on August 31, 2009 at 10:53 am By:
Concerns About Anti-Obesity Drug Orlistat: US authorities are investigating concerns that anti-obesity drug Orli.. http://bit.ly/GsWAZ
FDA reviewing reports of liver injury with orlistat
endocrinetoday.com — “The FDA has issued early communication about an ongoing safety review of adverse event reports of liver injury among people taking orlistat.” View full resource at endocrinetoday.com
Most Recently Shared on August 25, 2009 at 9:02 pm By:
#FDA reviewing reports of liver injury with #orlistat. Read about the early communication review here @ http://ow.ly/ljAu
Petition to FDA to Ban Orlistat (Alli, Xenical)
citizen.org — “Petition to FDA to Ban Orlistat (Alli, Xenical)” View full resource at citizen.org
Most Recently Shared on April 14, 2011 at 7:36 pm By:
Sidney Wolfe, MD Physician, Doctor, and Internist
To #FDA: dangerous #diet drugs Alli and Xenical should be removed from the market http://bit.ly/dUzFl9 http://bit.ly/ieQX9s
FDA Alert: Orlistat (marketed as Alli and Xenical): Labeling Change
drugs.com — “FDA Alert: Orlistat (marketed as Alli and Xenical): Labeling Change” View full resource at drugs.com
Most Recently Shared on May 27, 2010 at 10:27 am By:
FDA Alert - Labeling Change for Orlistat (marketed as Alli and Xenical) - http://bit.ly/aJgwZA
FDA warns of hepatotoxicity risk with Xenical and Alli (orlistat) - MPR
empr.com — “The FDA has notified healthcare professionals and consumers that it is reviewing new safety information regarding reports of liver-related adverse events in patients taking orlistat, which is marketed in the U.S. as Xenical (from Roche) and Alli (from GlaxoSmithKline).” View full resource at empr.com
Most Recently Shared on August 25, 2009 at 3:12 pm By:
MPR News: FDA warns of hepatotoxicity risk with Xenical and Alli (orlistat): The FDA has notified healt.. http://bit.ly/BdTnB
ingentaconnect Orlistat/lopinavir/ritonavir interaction: Decreased lopinavir CSF...
ingentaconnect.com — “ingentaconnect Orlistat/lopinavir/ritonavir interaction: Decreased lopinavir CSF...” View full resource at ingentaconnect.com
Most Recently Shared on May 11, 2011 at 8:37 pm By:
Orlistat/lopinavir/ritonavir interaction: Decreased lopinavir CSF concentration, leading to HIV-related meningo-... http://bit.ly/iPYKOe
FDA Alert: Orlistat (marketed as Alli and Xenical): Early Communication about an Ongoing Safety Review
drugs.com — “FDA Alert: Orlistat (marketed as Alli and Xenical): Early Communication about an Ongoing Safety Review” View full resource at drugs.com
Most Recently Shared on August 25, 2009 at 10:08 pm By:
FDA Alert - FDA Reviewing Reports of Liver Failure with Weight Loss Drug Orlistat (marketed as Alli and Xenical) - http://bit.ly/3E8nyv
Weight Loss Medication Xenical, Alli (orlistat) Rare Cases Of Liver Injury Announcement By FDA
medicalnewstoday.com — “There may be rare occurrences of severe liver injury in patients taking active ingredient orlistat, marketed as Xenical or Alli - a weight-loss medication, says the Food and Drug Administration (F” View full resource at medicalnewstoday.com
Most Recently Shared on May 26, 2010 at 11:06 pm By:
Weight Loss Medication Xenical, Alli (orlistat) Rare Cases Of Liver Injury Announcement By FDA http://mnt.to/3D8Q #healthnews
Can #orlistat help reduce #weight and enhance self-esteem in motivated teenagers with psychiatric comorbidities?
currentpsychiatry.com — “Can #orlistat help reduce #weight and enhance self-esteem in motivated teenagers with psychiatric comorbidities?” View full resource at currentpsychiatry.com
Most Recently Shared on October 23, 2009 at 5:35 pm By:
Current Psychiatry Medical Journal and Psychiatry
Can #orlistat help reduce #weight and enhance self-esteem in motivated teenagers with psychiatric comorbidities? http://bit.ly/24wn0d
FDA Drug Safety Communication: Completed safety review of Xenical/Alli (orlistat) and severe liver injury
fda.gov — “FDA Drug Safety Communication: Completed safety review of Xenical/Alli (orlistat) and severe liver injury” View full resource at fda.gov
Most Recently Shared on May 26, 2010 at 3:22 pm By:
Samantha Heller, RD Dietitian and Nutritionist
FDA: Rare Cases of Liver Injury Reported with Use of Xenical, Alli. http://lb.vg/rx61z
FDA Issues Early Communication About Ongoing Safety Review Of Weight Loss Drug Orlistat
medicalnewstoday.com — “The U.S. Food and Drug Administration announced that it is reviewing adverse event reports of liver injury in patients taking the weight loss drug orlistat, marketed as the prescription drug Xenic” View full resource at medicalnewstoday.com
Most Recently Shared on January 24, 2010 at 2:30 am By:
MNT Weight Loss News Health News
FDA Issues Early Communication About Ongoing Safety Review Of Weight Loss Drug Orlistat: The U.S. Food and Drug .. http://bit.ly/i2t2n
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
Advertisement
